天演药业 ADAG 深 沪
等待开盘 08-27 09:30:00 美东时间
3.85
+0.030
+0.79%
华盛通- 最 高4.09
- 今 开3.97
- 成交量 12.21万股
- 最 低 3.82
- 昨 收 3.82
- 总市值 32.31万
- 52周最高 4.85
- 市盈率 静 --
- 换手率 0.15%
- 52周最低 1.30
- 委 比 68.42%
- 总股本 8.39万
- 历史最高 31.83
- 量 比 0.80
- 振 幅 7.07%
- 历史最低 0.90
- 每 手 1
- 风险率 0.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Adagene to Participate in Three Upcoming Investor Conferences
Adagene Inc. announced that its senior management will participate in three upcoming investor conferences in New York: the 2026 Cantor Global Healthcare Conference on September 11, 2026; the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026; and the H.C. Wainwright 28th Annual Global Investment Conference on September 16, 2026. The events will include Fireside Chats and 1x1 meetings. Adagene, a biotechnology company sp...
08-20 12:00
天演药业（ADAG）上半年实现净收入160万美元 研发投入同比增16.2%
经济观察网 天演药业（ADAG）2026年上半年中报披露，其录得净收入且研发投入保持增长，净亏损同比有所扩大。 业绩经营情况： 8月13日发布中报：上半年净收入...
08-18 05:59
Adagene H1 Adj. EPS $(0.20) Misses $(0.10) Estimate, Sales $1.620M
Adagene (NASDAQ:ADAG) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.10) by 100 percent. This is a 5.26 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $1.620 million in sales this quarter.
08-12 19:33
药物受理最新动态：天演药业（苏州）有限公司ADG138注射液新药申请获受理
国家药品监督管理局药品审评中心数据显示，2026年5月28日，天演药业（苏州）有限公司的ADG138注射液申请已获受理，受理号为CXSL2600579。 ...
05-28 20:15
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Akari Therapeutics (NASDAQ:AKTX) stock increased by 40.3% to $7.21 dur...
05-22 05:06
Adagene's Muzastotug Triplet Regimens Show Superior Response Rates In HCC And MSS CRC, Highlighting Improved Anti-CTLA-4 Tumor-Targeting At AACR 2026
Triple combination of muzastotug + atezolizumab + bevacizumab resulted in much higher overall response rates (ORR) compared to the atezolizumab + bevacizumab control arm (66.7% vs. 32.5%, respectively by Investigator per
04-18 04:03
